| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $218K | -73.8% |
| R&D Expense | $75.6M | -12.8% |
| SG&A Expense | $37.0M | -22.2% |
| Operating Income | -$112.4M | +21.9% |
| Pre-tax Income | -$107.3M | +20.6% |
| Income Tax | $0 | — |
| Net Income | -$107.3M | +20.6% |
| EPS (Basic) | -$3.95 | +35.1% |
| EPS (Diluted) | -$3.95 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.8M | +359.9% |
| Short-term Investments | $28.3M | -78.4% |
| Accounts Receivable | $1.2M | -50.1% |
| Current Assets | $97.8M | -36.1% |
| Total Assets | $113.2M | -33.8% |
| Current Liabilities | $35.3M | -17.0% |
| Total Liabilities | $44.7M | -16.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$104.1M | +16.3% |
| Capital Expenditures | $488K | +52.0% |
| Investing Cash Flow | $104.1M | +19.1% |
| Financing Cash Flow | $51.5M | +930.5% |
| Free Cash Flow | -$104.6M | +16.1% |
| +35.1% |
| Stockholders' Equity |
| $68.5M |
| -41.6% |